Pacira Pharmaceuticals buy melinda
Start price
22.03.17
/
50%
€42.17
Target price
26.04.17
€80.28
Performance (%)
0.53%
End price
26.04.17
€42.39
Summary
This prediction ended on 26.04.17 with a price of €42.39. The BUY prediction by melinda for Pacira Pharmaceuticals closed nearly unchanged. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Pacira Pharmaceuticals | -3.846% | -3.846% | -58.609% | -74.490% |
iShares Core DAX® | 1.518% | 3.456% | 25.970% | 21.597% |
iShares Nasdaq 100 | 1.240% | 2.983% | 31.325% | 39.177% |
iShares Nikkei 225® | 2.808% | 2.743% | 19.597% | 5.115% |
iShares S&P 500 | 0.403% | 2.187% | 28.624% | 40.348% |
Comments by melinda for this prediction
In the thread Pacira Pharmaceuticals diskutieren
$ PCRX bekräftigt mit einem Outperform bei Wedbush. $ 89 PT
A +
(Vom Mitglied beendet)
Stopped prediction by melinda for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€35.51
29.01.19
29.01.19
€42.39
02.05.19
02.05.19
19.77%
02.05.19
02.05.19
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€36.31
27.08.16
27.08.16
€40.59
27.02.17
27.02.17
7.95%
27.02.17
27.02.17
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€36.95
19.10.15
19.10.15
€63.14
15.12.15
15.12.15
78.88%
15.12.15
15.12.15